Skip to main content

Pharming Group announces a change in its minority holding in BioConnection B.V. Following receipt of an offer for all shares in BioConnection by Gimv, a European investment company listed on Euronext Brussels, the existing shareholders (including Pharming) reached agreement with Gimv today on the sale of all issued and outstanding shares to a new holding company incorporated by Gimv for BioConnection, followed by a partial re-investment by  existing shareholders of the purchase price in the share capital of that new holding company.

"We are pleased to continue our investment into BioConnection, as they have been an excellent partner for Pharming for many years. We look forward to continuing to support BioConnection as it continues to grow"

- Sijmen de Vries - CEO
Cookies: This website uses cookies Check the cookies page for more information Accept Decline